- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
May 24, 2022
On Tuesday, May 24, 2022, AVAC and partners held Processes, the second webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the changed landscape of clinical research and the potential for experimental medicine vaccine trials in the current research environment.
Moderators:
- Stacey Hannah, AVAC's Director of Research Engagement
- Bill Snow, AVAC Senior Advisor
Panelists:
- Robin Shattock, Imperial College
- Gail Broder, HVTN
- Pontiano Kaleebu, MRC/UVRI & LSHTM Uganda Research Unit
Recording and Slides: YouTube / Robin Shattock's Slides / Gail Broder's Slides / Pontiano Kaleebu's Slides